TGFB1 and myocardial infarction: The results showed that after treatment with rEgAgB8/2, the levels of pro-inflammatory factors TNF-α and IL-1β was significantly decreased, while the levels of IL-10 and TGF-β significantly increased in both sera and MI tissues of the mice with MI.